The Psilocybin Access Rights campaign group is urging public action to change the scheduling of psilocybin, currently a Schedule 1 drug, to enable critical research and treatment access.
Timmy Davis emphasizes that the current political landscape, with a strong Labour majority and support from the Liberal Democrats and Greens, presents a unique opportunity for drug policy reform concerning psilocybin.
Evidence suggests psilocybin could assist in treating various serious mental health conditions, including depression and addiction, which necessitates urgent calls for its reclassification to facilitate research.
The PAR campaign seeks to mobilize public support for an open letter to the Home Office, highlighting the urgency of reviewing psilocybin's status for both research and patient access.
Collection
[
|
...
]